KV Pharmaceuticals Case Study

3989 Words16 Pages
Introduction

Business ethics is an extremely important topic in our world today. This is especially true because of the fact that we live in a changing society where it has become increasingly common to see more and more cases of companies that participate in illegal, immoral and unethical activities. So that we can prevent these behaviors, it is necessary to study and understand how these situations can occur and what we can do to prevent them from happening.

In this research paper, we will examine in detail the case of KV Pharmaceuticals, also known as KV. We will discuss a few major areas of topic that include how and why these events took place, as well as what could have been done to prevent them. Next, we will take a look at our stakeholder map and describe how each was affected. Then, we will include some suggestions for prevention and present an industry leader with model behavior.

Section I-

Reasons for KV Pharmaceutical’s downfall

There were several reasons why KV Pharmaceuticals deviated from their corporate values. Many of them had to do with the conduct and misguidance of its officers and directors, particularly former CEO Marc Hermelin. He and many others led the company into a downward spiral of transgressions which resulted in recalls, halted production, counterfeit stock information, noncompliance with FDA regulations, issues with budgeting controls, and layoffs for KV Pharmaceutical’s subsidiaries. All of these problems led to a vast amount of lawsuits and as a result, have cost the company millions of dollars.

Noncompliance with FDA regulations

The problems at KV Pharmaceuticals began in May 2008 when a distributor in Canada and a pharmacy in California complained to the company and the ETHE...

... middle of paper ...

...be-Democrat." St. Louis News, Cardinals, Sports, Jobs, Classifieds, Entertainment & Weather. 3 Mar. 2010. Web. 30 Mar. 2010. .

"Stakeholder -." Wikipedia, the Free Encyclopedia. Web. Mar. 2010. .

"Welcome to the United States Department of Justice." PE Html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN""http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"Welcome to the United States Department of Justice. 10 Mar. 2010. Web. 30 Mar. 2010. .

"WNYT.com - K-V Pharma Wont Resume Shipping until 4Q or Later." WNYT.com - Capital Region News, Weather and Sports from NEWSCHANNEL 13. 26 Mar. 2010. Web. Mar. 2010. .
Show More
Related

More about KV Pharmaceuticals Case Study

Open Document